close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Eli Lilly and Co Novo Nordisk A/S Altimmune Inc
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Eli Lilly and Co Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Novo Nordisk A/S Eli Lilly and Co Pharmaceuticals
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Pharmaceuticals Eli Lilly and Co Biogen Inc
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Biotech and Pharmaceuticals Health care industry US: News
From CNBC.com News
Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell
Tags Meta Platforms Inc Mad Money Amazon/com Inc
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Asia Markets Meta Platforms Inc Pharmaceuticals
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Asia Markets Meta Platforms Inc Pharmaceuticals
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Zealand Pharma A/S Pharmaceuticals Markets
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags UnitedHealth Group Inc Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Health & Science Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Health & Science Business Companies
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Business U/S/ Markets Investment strategy
From CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
Tags Tesla Inc Markets Investing
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags US: News Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
Tags Investment Strategy stocks Apple Inc
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Mondelez International Inc Wall Street Exchange/traded funds
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Cigna Corp CVS Health Corp Healthy Returns
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Nasdaq Inc World Markets Tesla Inc
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Electric vehicles Medication Inflation
From CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
Tags Business Companies Science
From CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags Alnylam Pharmaceuticals Inc Exchange/traded funds Markets
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Viking Therapeutics Inc Zealand Pharma A/S Health & Science
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
Tags Investment Strategy stocks Business News
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Novo Nordisk A/S Eli Lilly and Co Asia News
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Health care industry US: News Biotech and Pharmaceuticals
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Markets Zealand Pharma A/S Pharmaceuticals
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Health & Science Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Biotechnology Companies Business
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today